Stay updated on Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi

Sign up to get notified when there's something new on the Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The Taiwan site entry was updated from Taoyuan District, Taiwan, 333 to Taoyuan, Taiwan, 333, aligning the location with city-level nomenclature.
    Difference
    0.0%
    Check dated 2026-05-03T15:49:10.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The page’s displayed update/version information was refreshed, adjusting the revision number and associated date markers. This reflects a site record update or posting/version maintenance rather than substantive changes to the clinical study information.
    Difference
    0.1%
    Check dated 2026-04-26T13:32:42.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T04:48:24.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Padua, Italy (35128) has been replaced with Padova, Italy (35128) for the Italy site entry.
    Difference
    0.0%
    Check dated 2026-04-04T19:28:14.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T09:17:18.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Publication entry updated to reflect a full 2026 Clin Lung Cancer article by the SAVANNAH study authors with a DOI. The previous 'Online ahead of print' citation was removed.
    Difference
    0.1%
    Check dated 2026-03-06T18:02:19.000Z thumbnail image

Stay in the know with updates to Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi page.